hyperthyroidism and tirzepatide Dual Glucagon-Like Peptide-1 (GLP-1) Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Use Tirzepatide and Thyroid Nodules: Safety

PMID: 20609377 Maes M, Rachayon M, Jirakran K, Sodsai P, Klinchanhom S, Gaecki P, et al

Contact us for a consultation about semaglutide weight loss treatments

Your dose may need adjustment, or your provider may recommend spacing out your injections or temporarily pausing treatment

The injection combines lipotropic substances

The study found that treatment with Tesofensine led to greater weight reduction compared to placebo, with mean weight loss percentages of 4.5%, 9.2%, and 10.6% higher for the 0.25 mg, 0.5 mg, and 1.0 mg doses, respectively

Novo Nordisk launched the Phase 3 ESSENCE trial to put this idea to the test